Avantgen Inc
CAGE Code: 4NTY2
NCAGE Code: 4NTY2
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 186489899
Summary
Avantgen Inc is an Active Commercial Supplier with the Cage Code 4NTY2 and is tracked by Dun & Bradstreet under DUNS Number 186489899..
Address
6162 Nancy Ridge Dr Ste 150
San Diego CA 92121-3223
United States
Points of Contact
Related Information
People who viewed this 'CAGE Code' also viewed...
Technet Jarecki Engineering Circle Intl Temple Ralph Corona Consulting Btg Technology Systems Quality Technology Services, Inc. P&D Consultants Inc. Nova Commercial Co Inc Precision Metal Products Co Frut Stix Co Div Of Lafayette Foods Lynx Systems Kjos Neil A Music Co Circle M Construction Lopez Dunn Ramirez And Associates Morton Equipment And Supply Company G G B Drywall Co Ocean Sensors Inc King Communications Compucom Systems Inc
Frequently Asked Questions (FAQ) for CAGE 4NTY2
- What is CAGE Code 4NTY2?
- 4NTY2 is the unique identifier used by NATO Organizations to reference the physical entity known as Avantgen Inc located at 6162 Nancy Ridge Dr Ste 150, San Diego CA 92121-3223, United States.
- Who is CAGE Code 4NTY2?
- 4NTY2 refers to Avantgen Inc located at 6162 Nancy Ridge Dr Ste 150, San Diego CA 92121-3223, United States.
- Where is CAGE Code 4NTY2 Located?
- CAGE Code 4NTY2 is located in San Diego, CA, USA.
Contracting History for CAGE 4NTY2 Most Recent 25 Records
- 75N92022C00003
- Rapid Acceleration Of Diagnostics (Radx) Program: Tech Project #7360 - Highly Sensitive Rapid Test Kit For Sars-Cov-2 That Does Not Require A Reader
- 22 Nov 2021
- Rapid Acceleration Of Diagnostics (Radx) Program: Tech Project #7360 - Highly Sensitive Rapid Test Kit For Sars-Cov-2 That Does Not Require A Reader
- National Institutes Of Health Nhlbi
- Department Of Health And Human Services (Hhs)
- $3,750,864.00
- Department Of Health And Human Services (Hhs)
- 75N92022C00003
- Rapid Acceleration Of Diagnostics (Radx) Program: Tech Project #7360 - Highly Sensitive Rapid Test Kit For Sars Cov-2 That Does Not Require A Reader
- 23 Sep 2022
- Rapid Acceleration Of Diagnostics (Radx) Program: Tech Project #7360 - Highly Sensitive Rapid Test Kit For Sars Cov-2 That Does Not Require A Reader
- National Institutes Of Health Nhlbi
- Department Of Health And Human Services (Hhs)
- $3,750,864.00
- Department Of Health And Human Services (Hhs)
- 75N92022C00003
- Rapid Acceleration Of Diagnostics (Radx) Program: Tech Project #7360 - Highly Sensitive Rapid Test Kit For Sars Cov-2 That Does Not Require A Reader
- 17 Nov 2022
- Rapid Acceleration Of Diagnostics (Radx) Program: Tech Project #7360 - Highly Sensitive Rapid Test Kit For Sars Cov-2 That Does Not Require A Reader
- National Institutes Of Health Nhlbi
- Department Of Health And Human Services (Hhs)
- $3,750,864.00
- Department Of Health And Human Services (Hhs)
- 75N92022C00003
- Rapid Acceleration Of Diagnostics (Radx) Program: Tech Project #7360 - Highly Sensitive Rapid Test Kit For Sars Cov-2 That Does Not Require A Reader
- 22 Sep 2023
- Rapid Acceleration Of Diagnostics (Radx) Program: Tech Project #7360 - Highly Sensitive Rapid Test Kit For Sars Cov-2 That Does Not Require A Reader
- National Institutes Of Health Nhlbi
- Department Of Health And Human Services (Hhs)
- $3,750,864.00
- Department Of Health And Human Services (Hhs)
- 75N92022C00003
- Rapid Acceleration Of Diagnostics (Radx) Program: Tech Project #7360 - Highly Sensitive Rapid Test Kit For Sars Cov-2 That Does Not Require A Reader
- 21 Jan 2022
- Rapid Acceleration Of Diagnostics (Radx) Program: Tech Project #7360 - Highly Sensitive Rapid Test Kit For Sars Cov-2 That Does Not Require A Reader
- National Institutes Of Health Nhlbi
- Department Of Health And Human Services (Hhs)
- $3,750,864.00
- Department Of Health And Human Services (Hhs)
- 75N92022C00003
- Rapid Acceleration Of Diagnostics (Radx) Program: Tech Project #7360 - Highly Sensitive Rapid Test Kit For Sars Cov-2 That Does Not Require A Reader
- 19 Jan 2023
- Rapid Acceleration Of Diagnostics (Radx) Program: Tech Project #7360 - Highly Sensitive Rapid Test Kit For Sars Cov-2 That Does Not Require A Reader
- National Institutes Of Health Nhlbi
- Department Of Health And Human Services (Hhs)
- $3,750,864.00
- Department Of Health And Human Services (Hhs)
- 75N92022C00003
- Rapid Acceleration Of Diagnostics (Radx) Program: Tech Project #7360 - Highly Sensitive Rapid Test Kit For Sars Cov-2 That Does Not Require A Reader
- 16 Jun 2022
- Rapid Acceleration Of Diagnostics (Radx) Program: Tech Project #7360 - Highly Sensitive Rapid Test Kit For Sars Cov-2 That Does Not Require A Reader
- National Institutes Of Health Nhlbi
- Department Of Health And Human Services (Hhs)
- $3,750,864.00
- Department Of Health And Human Services (Hhs)
- 75N93021C00040
- Development Of Rabbit Monoclonal Antibodies For Ferret Biomarkers
- 22 Dec 2021
- Development Of Rabbit Monoclonal Antibodies For Ferret Biomarkers
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $356,021.00
- Department Of Health And Human Services (Hhs)
- 75N93021C00040
- Development Of Rabbit Monoclonal Antibodies For Ferret Biomarkers
- 28 Jul 2021
- Development Of Rabbit Monoclonal Antibodies For Ferret Biomarkers
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $356,021.00
- Department Of Health And Human Services (Hhs)
- 75N93021C00040
- Development Of Rabbit Monoclonal Antibodies For Ferret Biomarkers
- 31 May 2022
- Development Of Rabbit Monoclonal Antibodies For Ferret Biomarkers
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $356,021.00
- Department Of Health And Human Services (Hhs)
- 75N93021C00040
- Eo14042 - Development Of Rabbit Monoclonal Antibodies For Ferret Biomarkers
- 15 Oct 2021
- Eo14042 - Development Of Rabbit Monoclonal Antibodies For Ferret Biomarkers
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $356,021.00
- Department Of Health And Human Services (Hhs)
- 75N93021C00040
- Development Of Rabbit Monoclonal Antibodies For Ferret Biomarkers
- 16 Nov 2021
- Development Of Rabbit Monoclonal Antibodies For Ferret Biomarkers
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $356,021.00
- Department Of Health And Human Services (Hhs)
- 75N93021C00047
- Development Of Rapid And Point-Of-Care Diagnostic Kit For Hepatitis C Virus Detection
- 24 Aug 2021
- Development Of Rapid And Point-Of-Care Diagnostic Kit For Hepatitis C Virus Detection
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $300,000.00
- Department Of Health And Human Services (Hhs)
- 75N93021C00047
- Development Of Rapid And Point-Of-Care Diagnostic Kit For Hepatitis C Virus Detection
- 15 Oct 2021
- Development Of Rapid And Point-Of-Care Diagnostic Kit For Hepatitis C Virus Detection
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $300,000.00
- Department Of Health And Human Services (Hhs)
- 75N93021C00047
- Development Of Rapid And Point-Of-Care Diagnostic Kit For Hepatitis C Virus Detection
- 20 Jul 2023
- Development Of Rapid And Point-Of-Care Diagnostic Kit For Hepatitis C Virus Detection
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $300,000.00
- Department Of Health And Human Services (Hhs)
- 75N93021C00040
- Development Of Rabbit Monoclonal Antibodies For Ferret Biomarkers
- 6 Jul 2023
- Development Of Rabbit Monoclonal Antibodies For Ferret Biomarkers
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $356,021.00
- Department Of Health And Human Services (Hhs)
- 75N93021C00047
- Development Of Rapid And Point-Of-Care Diagnostic Kit For Hepatitis C Virus Detection
- 14 Jun 2022
- Development Of Rapid And Point-Of-Care Diagnostic Kit For Hepatitis C Virus Detection
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $300,000.00
- Department Of Health And Human Services (Hhs)
- 75N91020C00018
- Eo14042-Topic 372: Development And Validation Of Non-Mouse Reagents To Enable Preclinical Development Of Novel Therapeutics
- 24 Jun 2022
- Eo14042-Topic 372: Development And Validation Of Non-Mouse Reagents To Enable Preclinical Development Of Novel Therapeutics
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $1,995,852.00
- Department Of Health And Human Services (Hhs)
- 75N91020C00018
- Topic 372: Development And Validation Of Non-Mouse Reagents To Enable Preclinical Development Of Novel Therapeutics
- 15 Sep 2020
- Topic 372: Development And Validation Of Non-Mouse Reagents To Enable Preclinical Development Of Novel Therapeutics
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $1,995,852.00
- Department Of Health And Human Services (Hhs)
- 75N91020C00018
- Eo14042-Topic 372: Development And Validation Of Non-Mouse Reagents To Enable Preclinical Development Of Novel Therapeutics
- 23 Mar 2022
- Eo14042-Topic 372: Development And Validation Of Non-Mouse Reagents To Enable Preclinical Development Of Novel Therapeutics
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $1,995,852.00
- Department Of Health And Human Services (Hhs)
- 75N91020C00018
- Eo14042-Topic 372: Development And Validation Of Non-Mouse Reagents To Enable Preclinical Development Of Novel Therapeutics
- 2 Nov 2021
- Eo14042-Topic 372: Development And Validation Of Non-Mouse Reagents To Enable Preclinical Development Of Novel Therapeutics
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $1,995,852.00
- Department Of Health And Human Services (Hhs)
- 75N91020C00018
- Topic 372: Development And Validation Of Non-Mouse Reagents To Enable Preclinical Development Of Novel Therapeutics
- 1 Sep 2023
- Topic 372: Development And Validation Of Non-Mouse Reagents To Enable Preclinical Development Of Novel Therapeutics
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $1,995,852.00
- Department Of Health And Human Services (Hhs)
- 75N91018C00041
- Igf::Ot::Igf Topic 372 - Sbir Phase I: Development And Validation Of Non- Mouse Reagents To Enable Preclinical Development Of Novel Therapeutics - Moonshot
- 13 Sep 2018
- Igf::Ot::Igf Topic 372 - Sbir Phase I: Development And Validation Of Non- Mouse Reagents To Enable Preclinical Development Of Novel Therapeutics - Moonshot
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $299,854.00
- Department Of Health And Human Services (Hhs)